Antiretroviral Medications Flashcards
ART that will exacerbate Hep B if discontinued? [3]
TAF, TDF, lamivudine, emtricitabine.
What is 3TC/FTC?
Lamivudine, emtricitabine.
FTC side effect?
Skin hyperpigmentation
What CD4 and viral load can abacavir be started at?
CD4 >200, viral load <100,000
What HLA needs to be tested prior to abacavir use?
B*5701
Abacavir has what side effect?
MI in cohort studies
ABC?
Abacavir
Name the NRTIs [6]
Lamivudine, emtricitabine, abacavir, TAF, TDF, zidovudine
Name the 3 NNRTIs
Efavirenz, rilpivirine, doravirine
EFV
Efavirenz
RPV
rilpivirine
DOR
doravirine
Efavirenz side effects?
Vivid dreams, dizziness, somnolence, insomnia, hallucinations, [50% with CNS toxicity] depression, SI, rash
How should rilpivirine be taken?
With food [400 cal], needs acid [PPI contraindicated, H2 needs to be 12 hours before or 4 hours after], Needs >200 CD4 and viral load <100,000
Rilpivirine side effects?
QT prolongation, neuropsychiatric.
Name the 4 INSTIs [integrase strand transfer inhibitors]
Raltegravir, Dolutegravir, bictegravir [preferred]. Elvitegravir [alt].
RAL
Raltegravir
DTG
Dolutegravir
BIC
Bictegravir
Raltegravir side effects
CPK elevation, weakness, rhabdo
Dolutegravir claim to fame?
Higher barrier to resistance than RAL or ETG. If there is preexisting INSTI resistance BID dosing
DTG dosing considerations?
Calcium, iron, zinc, antacids reduce DTGs efficacy and caution is needed regarding timing.
DTG pregnancy considerations?
Neural tube defects. Ensure adequate birth control.
BIC claim to fame?
Does not need boosting, high barrier to resistance with activity to most INSTI-resistant variants
ETG
Elvitegravir
Which INSTI needs boosting and with what?
ETG [Elvitegravir] with cobicistat
Name the 3 protease inhibitors
Ritonavir, darunavir [DRV] [preferred], atazanavir [ATV] [alt]
DRV
darunavir
ATV
atazanavir
Darunavir side effects
Sulfa drug, rash in 10%, erythema multiforme, SJS, TEN
Atazanavir side effects
Kidney and gall stones, PR prolongation, indirect hyperbilirubinemia.
Atazanavir dosing considerations
Needs acid, do not use with PPI, boosting is preferred. MUST be boosted with TAF
MVC
Maraviroc
Maraviroc contraindications?
Avoid in dual/mixed CXCR4-tropic HIV-1 infection.
T20?
Enfuvirtide
What is Enfuvirtide?
Fusion inhibitor, BID injection.
Didanosine SE [DDI] (Not frequently used)
Pancreatitis, peripheral neuropathy, lactic acidosis [life threatening]
Stavudine SE [d4T] (Not frequently used)
Lipodystrophy, peripheral neuropathy, lactic acidosis, pancreatitis
Zidovudine SE [AZT] (Not frequently used)
Anemia, neutropenia, myopathy, lipodystrophy
Etravirine [ETR] SE (Not frequently used)
Rash - this can be a life threatening hypersensitivity reacation
Nevirapine [NPV] SE (Not frequently used)
Hepatotoxicity
Fosamprenavir [FPV] SE (Not frequently used)
SJS
Indinavir [IDV] SE (Not frequently used)
Renal stones
Lopinavir [LPV] SE (Not frequently used)
Diarrhea
Nelfinavir [NFV] SE (Not frequently used)
ONLY UNBOOSTED PI. Hepatoxicity in moderate to severe liver disease
Saquinavir [SQV] SE (Not frequently used)
Arrhythmia
Tipranavir [TPV] SE (Not frequently used)
ICH, hepatotoxicity
Maraviroc [MVC] SE (Not frequently used)
Hepatotoxicity preceded by severe rash or system allergic reaction.
Four empiric regiments for HAART recommended.
INSTI + 2 NRTIs BIC/TAF/FTC DTG/ABC/3TC DTG + TAF/FTC RAL + TAF/FTC
What is virologic failure?
Inability to achieve or maintain HIV RNA <200
Most common type of HIV resistance mutation?
NNRTI mutations
Class side effect of NRTI? [4]
Lactic acidosis, hepatitis steatosis, lipoatrophy
Class SE of NNRTI? [1]
Rash [TEN, SJS]
Class SE of INSTI? [1]
Rarely depression or SI
Class SE of PI? [4]
Dyslipidemia, hyperglycemia, insulin resistance, lipodystrophy
MOA of NRTI?
Structural analogs of normal nucleosides or nucleotides that terminate HIV DNA synthesis by targeting reverse transcriptase
MOA Of NNRTI?
Binds noncompetitively to reverse transcriptase and blocks polymerization of the viral DNA
MOA of INSTI?
Binds to HIV integrase and blocks the insertion of HIV pro viral DNA into host cells thus inhibiting HIV-catalyzed strand transfer
MOA of PI?
Binds to HIV protease preventing the packaging of virions
In general what are the drug classes in an initial regimen for HIV treatment?
2 NRTI + INSTI
Name the 4 most common starting regimens for treatment of HIV
- TAF/FTC/BIC [NRTI/NRTI/INSTI]
- ABC/3TC/DTG [NRTI/NRTI/INSTI]
- TAF/FTC + DTG [NRTI/NRTI + INSTI]
- TAF/FTC + RAL [NRTI/NRTI + INSTI]
When should HIV resistance testing be done?
If there is virologic failure while patient is taking failing regimen or within 4 weeks of discontinuing.
If a patient has a suppressed viral load but CD4 count has not recovered what medication change should be made?
None.
What is the prevalence of HIV resistance at baseline? What is the most common type of resistance?
5-15%
NNRTI resistance
What type of resistance testing should be done on all patients prior to starting ART?
- Protease Inhibitors
2. Reverse Transcriptase
What is genotypic resistance testing?
Looks for viral genetic mutations associated with specific HIV drugs.